Lundbeck booze pill for EU
March 1, 2013Sales and Marketing Lundbeck, alcohol, selincro
Lundbeck’s novel pill Selincro has been given European marketing authorisation to help patients with a drink problem to cut down. …
RSA welcomes pan-European consultant
February 28, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing rsa
Life sciences executive search and interim management firm RSA has announced that Dr Theo de Roij has joined the pan-European …
Eliquis approved by NICE
February 28, 2013Sales and Marketing BMS, Eliquis, NICE, Pfizer
In a move which will cheer Bristol-Myers Squibb and Pfizer, NICE has recommended oral blood-thinner Eliquis for use on the …
ABPI moves to improve compliance
February 28, 2013Sales and Marketing ABPI, NHS, alltrials, goldaccre, whiehead
The ABPI has fired its latest salvo in the clinical trial transparency debate by announcing it will appoint a new …
UCB warns of data ‘voyeurism’
February 27, 2013Research and Development, Sales and Marketing EFPIA, UCB, VBP, transparancy
UCB chief executive Roch Doliveux has attacked the idea of making all clinical trial data publicly available, saying it could …
Roche increases data access
February 27, 2013Research and Development, Sales and Marketing ABPI, BMJ, Goldacre, Roche
Roche has launched a new process designed to enable greater access to its clinical trial data for researchers from outside …
The King’s Fund’s Anna Dixon joins Department of Health
February 27, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dixon, NHS, king's fund
Director of Policy at The King’s Fund Dr Anna Dixon will be joining the Department of Health in early May …
Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate
February 27, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead
In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …
Merck suffers brain cancer reverse
February 26, 2013Sales and Marketing Merck, cilengitide
Merck’s oncology programme has suffered a setback as a Phase III trial of its investigational integrin inhibitor cilengitide failed in …
Probe launched as deaths prompt Omontys recall
February 26, 2013Manufacturing and Production Affymax, Takeda, omontys, recall
Reports of three fatal reactions linked to administration of Takeda and Affymax’ Omontys anaemia treatment have led to a recall …
Elan sceptical of Royalty
February 26, 2013Sales and Marketing Elan, FDA, Tysabri, royalty pharma
Elan Corporation has poured tepid water on private equity firm Royalty Pharma’s putative offer this week for the Irish biotech …
Pharma manufacturing news in brief
February 26, 2013Manufacturing and Production Baxter International, Bone Therapeutic, DSM Pharmaceutical Products and Chemtrix, Sovereign Pharmaceutical
Sovereign Pharma rapped by FDA, facility updates from Bone Therapeutics, Baxter and SHL, plus a continuous processing alliance between DSM …
Abbott, GSK cut staff at Irish facilities
February 26, 2013Manufacturing and Production Abbottt, GSK, Ireland
GlaxoSmithKline and Abbott have both announced job cuts at their facilities in Ireland in a blow to the country’s pharmaceutical …
Continuous processing production line set up in Finland
February 25, 2013Manufacturing and Production Finland, PROMIS
A specialist centre in Finland providing expertise in the continuous processing of pharmaceuticals, first envisaged in 2008, opened its doors …
Pharmalink Consulting appoints five consultants
February 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmalink Consulting
Regulatory affairs firm Pharmalink Consulting has announced the appointment and promotion of five consultants at their offices in the UK, …
Abbott seeks leukemia test
February 25, 2013Sales and Marketing AbbVie, Abbott, Janssen
Abbott is to team up with Janssen Biotech and biopharma firm Pharmacyclics to seek a diagnostic test for leukemia patients. …
FDA approves Kadcyla
February 25, 2013Herceptin, Roche, T-DM1
Roche’s new ‘smart bomb’ breast cancer drug Kadcyla has been approved by the FDA, giving it hope of replacing revenue …
$33m prizes for research
February 22, 2013Research and Development Breakthrough Prize in Life Sciences, Cancer, Facebook, google
Life science research has a new multi-million dollar prize from the founders of Facebook and Google.The not-for-profit Breakthrough Prize in …
Ariad expands in Europe
February 22, 2013Sales and Marketing Ariad, leukaemia, leukemia
The new European boss of Ariad Pharmaceuticals has sketched out the US firm’s plans for its next-generation leukaemia drug, which …
Roche censured for drunken conference antics
February 21, 2013Medical Communications, Sales and Marketing ABPI, PMCPA, Roche
The conduct of senior Roche employees has come under the spotlight following a complaint about drunkenness and poor behaviour at …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
